Murine
monoclonal antibody ZME-018 recognizes a 240 Kda
glycoprotein present on the surface of most human
melanoma cells and on over 80% of human biopsy specimens tested.
Gelonin is a ribosome-inactivating plant toxin similar in nature and rivaling the activity of
ricin A chain. ZME-018 was coupled to purified
gelonin using the
reagents SPDP and
2-iminothiolane. The ZME-
gelonin conjugate was purified by S-300 Sephacryl and
Blue Sepharose chromatography, removing unreacted
gelonin and antibody, respectively. PAGE analysis showed that ZME was coupled to 1, 2, or 3
gelonin molecules. The ZME-
gelonin conjugate was 10(6)-fold more active than
gelonin itself in inhibiting the growth of log-phase human
melanoma cells in culture. The
immunoconjugate was not cytotoxic to
antigen negative T-24 (human bladder
carcinoma) cells. Treatment of
melanoma cells with recombinant IFN-alpha or TNF substantially augmented the cytotoxicity of the
immunoconjugate while treatment with IFN-gamma had a minor effect. Using the human
tumor colony assay of
melanoma cells obtained from fresh biopsy specimens, greater than 90% growth suppression was observed in 2 of 4 samples tested at a concentration of 250 ng/ml. In addition, 25% growth suppression was observed with a third sample tested, and no growth suppression was observed in 1 sample. Thus, clonogenic
melanoma cells are sensitive in vitro to the cytotoxic activity of this
immunotoxin at concentrations which we presume are pharmacologically relevant.